Serious renal dysfunction after percutaneous coronary interventions can be predicted

American Heart Journal

Volumn 155, Issue 2, 2008, Pages 260-266

  Brown, Jeremiah R ^a,b   DeVries, James T ^b   Piper, Winthrop D ^b   Robb, John F ^b   Hearne, Michael J ^c   Ver Lee, Peter M ^d   Kellet, Mirle A ^e   Watkins, Mathew W ^f   Ryan, Thomas J ^e   Silver, M Theodore ^d   Ross, Cathy S ^b   MacKenzie, Todd A ^a,b   O'Connor, Gerald T ^a,b   Malenka, David J ^a,b  

^a DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^c CATHOLIC MEDICAL CENTER   (United States)

^d EASTERN MAINE MEDICAL CENTER   (United States)

^e MAINE MEDICAL CENTER   (United States)

^f FLETCHER ALLEN HEALTH CARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

ADULT; AGED; AORTA BALLOON; ARTICLE; CALIBRATION; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; DIALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SEX DIFFERENCE; UNITED STATES; VALIDATION PROCESS;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; AREA UNDER CURVE; CONTRAST MEDIA; FEMALE; HUMANS; KIDNEY DISEASES; LOGISTIC MODELS; MALE; MIDDLE AGED; MODELS, STATISTICAL; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; ROC CURVE;

EID: 38349162549     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.10.007     Document Type: Article

References (32)

1. Blackman D.J., Pinto R., Ross J.R., et al. Impact of renal insufficiency on outcome after contemporary percutaneous coronary intervention. Am Heart J 151 (2006) 146-152
2. Lindsay J., Apple S., Pinnow E.E., et al. Percutaneous coronary intervention-associated nephropathy foreshadows increased risk of late adverse events in patients with normal baseline serum creatinine. Catheter Cardiovasc Interv 59 (2003) 338-343
3. McCullough P.A., Adam A., Becker C.R., et al. Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol 98 (2006) 5K-13K
4. Barrett B.J., and Parfrey P.S. Clinical practice. Preventing nephropathy induced by contrast medium. N Engl J Med 354 (2006) 379-386
5. Mehran R., and Nikolsky E. Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int Suppl (2006) S11-S15
6. Bartholomew B.A., Harjai K.J., Dukkipati S., et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol 93 (2004) 1515-1519
7. Freeman R.V., O'Donnell M., Share D., et al. Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol 90 (2002) 1068-1073
8. Mehran R., Aymong E.D., Nikolsky E., et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 44 (2004) 1393-1399
9. Gruberg L., Mehran R., Dangas G., et al. Acute renal failure requiring dialysis after percutaneous coronary interventions. Catheter Cardiovasc Interv 52 (2001) 409-416
10. Gupta R., Gurm H.S., Bhatt D.L., et al. Renal failure after percutaneous coronary intervention is associated with high mortality. Catheter Cardiovasc Interv 64 (2005) 442-448
11. Rihal C.S., Textor S.C., Grill D.E., et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105 (2002) 2259-2264
12. Malenka D.J., and O'Connor G.T. A regional collaborative effort for CQI in cardiovascular disease. Northern New England Cardiovascular Study Group. Jt Comm J Qual Improv 21 (1995) 627-633
13. O'Connor G.T., Malenka D.J., Quinton H., et al. Multivariate prediction of in-hospital mortality after percutaneous coronary interventions in 1994-1996. Northern New England Cardiovascular Disease Study Group. J Am Coll Cardiol 34 (1999) 681-691
14. Levey A.S., Bosch J.P., Lewis J.B., et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 (1999) 461-470
15. Best P.J., Reddan D.N., Berger P.B., et al. Cardiovascular disease and chronic kidney disease: insights and an update. Am Heart J 148 (2004) 230-242
16. Goldberg A., Hammerman H., Petcherski S., et al. Inhospital and 1-year mortality of patients who develop worsening renal function following acute ST-elevation myocardial infarction. Am Heart J 150 (2005) 330-337
17. Ix J.H., Mercado N., Shlipak M.G., et al. Association of chronic kidney disease with clinical outcomes after coronary revascularization: the Arterial Revascularization Therapies Study (ARTS). Am Heart J 149 (2005) 512-519
18. Charlesworth D.C., Likosky D.S., Marrin C.A., et al. Development and validation of a prediction model for strokes after coronary artery bypass grafting. Ann Thorac Surg 76 (2003) 436-443
19. Nowicki E.R., Birkmeyer N.J., Weintraub R.W., et al. Multivariable prediction of in-hospital mortality associated with aortic and mitral valve surgery in Northern New England. Ann Thorac Surg 77 (2004) 1966-1977
20. Eagle K.A., Guyton R.A., Davidoff R., et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 110 (2004) 1168-1176
21. Piper W.D., Malenka D.J., Ryan Jr. T.J., et al. Predicting vascular complications in percutaneous coronary interventions. Am Heart J 145 (2003) 1022-1029
22. Levy E.M., Viscoli C.M., and Horwitz R.I. The effect of acute renal failure on mortality. A cohort analysis. JAMA 275 (1996) 1489-1494
23. Becker C.R., Davidson C., Lameire N., et al. High-risk situations and procedures. Am J Cardiol 98 (2006) 37K-41K
24. Davidson C., Stacul F., McCullough P.A., et al. Contrast medium use. Am J Cardiol 98 (2006) 42K-58K
25. Lameire N., Adam A., Becker C.R., et al. Baseline renal function screening. Am J Cardiol 98 (2006) 21K-26K
26. McCullough P.A., Adam A., Becker C.R., et al. Risk prediction of contrast-induced nephropathy. Am J Cardiol 98 (2006) 27K-36K
27. Stacul F., Adam A., Becker C.R., et al. Strategies to reduce the risk of contrast-induced nephropathy. Am J Cardiol 98 (2006) 59K-77K
28. Tumlin J., Stacul F., Adam A., et al. Pathophysiology of contrast-induced nephropathy. Am J Cardiol 98 (2006) 14K-20K
29. Briguori C., Airoldi F., D'Andrea D., et al. Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies. Circulation 115 (2007) 1211-1217
30. Recio-Mayoral A., Chaparro M., Prado B., et al. The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: the RENO Study. J Am Coll Cardiol 49 (2007) 1283-1288
31. Jones R.H., Hannan E.L., Hammermeister K.E., et al. Identification of preoperative variables needed for risk adjustment of short-term mortality after coronary artery bypass graft surgery. The Working Group Panel on the Cooperative CABG Database Project. J Am Coll Cardiol 28 (1996) 1478-1487
32. Nally Jr. J.V. Acute renal failure in hospitalized patients. Cleve Clin J Med 69 (2002) 569-574